Hilton Capital Management’s CVS Health CVS Stock Holding History

Hilton Capital Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-164,294	Closed	-$15.7M	–	119
2022 Q4	$15.7M	Hold	164,294	–	–	2.06%	11
2022 Q3	$15.7M	Sell	164,294 -2,791	-2%	-$276K	2.06%	11
2022 Q2	$15.5M	Sell	167,085 -4,016	-2%	-$392K	1.9%	13
2022 Q1	$17.3M	Buy	171,101 +94,435	+123%	+$9.92M	1.85%	17
2021 Q4	$7.91M	Buy	76,666 +3,021	+4%	+$279K	0.73%	37
2021 Q3	$6.25M	Buy	+73,645	New	+$6.17M	0.61%	41
2019 Q4	–	Sell	-200	Closed	-$13K	–	157
2019 Q3	$13K	Hold	200	–	–	﹤0.01%	260
2019 Q2	$11K	Hold	200	–	–	﹤0.01%	300
2019 Q1	$11K	Hold	200	–	–	﹤0.01%	302
2018 Q4	$13K	Hold	200	–	–	﹤0.01%	252
2018 Q3	$16K	Hold	200	–	–	﹤0.01%	247
2018 Q2	$13K	Buy	+200	New	+$13.2K	﹤0.01%	282
2016 Q3	–	Sell	-2,235	Closed	-$214K	–	126
2016 Q2	$214K	Buy	+2,235	New	+$223K	0.07%	83
2015 Q4	–	Sell	-77,227	Closed	-$7.45M	–	96
2015 Q3	$7.45M	Buy	77,227 +5,305	+7%	+$558K	2.56%	16
2015 Q2	$7.54M	Buy	+71,922	New	+$7.35M	2.13%	20

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Hilton Capital Management's CVS Position: Q1 2023 in Review

Hilton Capital Management sold out of CVS Health (CVS) in Q1 2023, closing a stake of 164,294 shares — an estimated $15.7M sold.

Hilton Capital Management first reported a position in CVS in Q2 2015 and held it in 15 quarters. The position peaked at $17.3M in Q1 2022. 2,267 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

Hilton Capital Management reported no remaining CVS Health position as of Q1 2023 after selling out during the quarter.
Hilton Capital Management sold 164,294 CVS Health shares in Q1 2023, an estimated $15.7M.
Hilton Capital Management first reported a position in CVS Health in Q2 2015 and held it in 15 quarters.
Hilton Capital Management's CVS Health position peaked at $17.3M in Q1 2022.
2,267 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on Hilton Capital Management's 13F filing for Q1 2023, filed 8 May 2023.